<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8100290</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">33953315</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">8100290</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">89118</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1038/s41598-021-89118-2</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>VOI of previous study in Talairach coordinates.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>VOI of previous study in Talairach coordinates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Region</th><th align="left">Mean X</th><th align="left">Mean Y</th><th align="left">Mean Z</th><th align="left">Std. Dev X</th><th align="left">Std. Dev Y</th><th align="left">Std. Dev Z</th><th align="left">Cluster size (Voxels)</th></tr></thead><tbody><tr><td align="left">R INS</td><td char="." align="char">44.05</td><td align="left">− 6.81</td><td char="." align="char">1.48</td><td char="." align="char">6.14</td><td char="." align="char">3.61</td><td char="." align="char">3.46</td><td align="left">993</td></tr><tr><td align="left">R INS</td><td char="." align="char">36.20</td><td align="left">− 15.13</td><td char="." align="char">14.11</td><td char="." align="char">2.22</td><td char="." align="char">8.21</td><td char="." align="char">5.61</td><td align="left">1753</td></tr><tr><td align="left">R DLPFC</td><td char="." align="char">24.01</td><td align="left">22.45</td><td char="." align="char">7.99</td><td char="." align="char">2.76</td><td char="." align="char">5.29</td><td char="." align="char">2.65</td><td align="left">498</td></tr><tr><td align="left">R SSC2</td><td char="." align="char">8.40</td><td align="left">− 54.54</td><td char="." align="char">57.95</td><td char="." align="char">4.44</td><td char="." align="char">5.31</td><td char="." align="char">3.06</td><td align="left">944</td></tr><tr><td align="left">R THLMS</td><td char="." align="char">5.10</td><td align="left">− 13.99</td><td char="." align="char">3.07</td><td char="." align="char">7.84</td><td char="." align="char">6.60</td><td char="." align="char">5.61</td><td align="left">3462</td></tr><tr><td align="left">R ACC</td><td char="." align="char">− 4.08</td><td align="left">− 5.08</td><td char="." align="char">39.15</td><td char="." align="char">6.13</td><td char="." align="char">15.07</td><td char="." align="char">3.86</td><td align="left">4797</td></tr><tr><td align="left">R PONS</td><td char="." align="char">0.76</td><td align="left">− 25.31</td><td char="." align="char">− 20.39</td><td char="." align="char">2.75</td><td char="." align="char">5.32</td><td char="." align="char">4.23</td><td align="left">1076</td></tr><tr><td align="left">L BA11</td><td char="." align="char">− 30.80</td><td align="left">8.05</td><td char="." align="char">− 0.19</td><td char="." align="char">11.25</td><td char="." align="char">7.89</td><td char="." align="char">10.25</td><td align="left">11,841</td></tr><tr><td align="left">L THLMS</td><td char="." align="char">− 23.76</td><td align="left">− 21.65</td><td char="." align="char">− 3.58</td><td char="." align="char">7.94</td><td char="." align="char">2.66</td><td char="." align="char">3.84</td><td align="left">1366</td></tr><tr><td align="left">L PFC</td><td char="." align="char">− 32.95</td><td align="left">31.70</td><td char="." align="char">30.25</td><td char="." align="char">3.55</td><td char="." align="char">5.31</td><td char="." align="char">3.87</td><td align="left">871</td></tr></tbody></table><table-wrap-foot><p>Several regions that were seen in a previous study linked with pain modulation with specific Talairach coordinates. Indication of left or right given as L or R respectively.</p><p><italic>INS</italic> insula, <italic>DLPFC</italic> dorsal lateral prefrontal cortex, <italic>SSC</italic> somatosensory cortex, <italic>THLMS</italic> thalamus, <italic>ACC</italic> anterior cingulate cortex, <italic>PFC</italic> prefrontal cortex, <italic>BA</italic> Brodmann Area.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">VOI of previous study in Talairach coordinates.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left">Region</th><th align="left">Mean X</th><th align="left">Mean Y</th><th align="left">Mean Z</th><th align="left">Std. Dev X</th><th align="left">Std. Dev Y</th><th align="left">Std. Dev Z</th><th align="left">Cluster size (Voxels)</th></tr></thead><tbody><tr><td align="left">R INS</td><td char="." align="char">44.05</td><td align="left">− 6.81</td><td char="." align="char">1.48</td><td char="." align="char">6.14</td><td char="." align="char">3.61</td><td char="." align="char">3.46</td><td align="left">993</td></tr><tr><td align="left">R INS</td><td char="." align="char">36.20</td><td align="left">− 15.13</td><td char="." align="char">14.11</td><td char="." align="char">2.22</td><td char="." align="char">8.21</td><td char="." align="char">5.61</td><td align="left">1753</td></tr><tr><td align="left">R DLPFC</td><td char="." align="char">24.01</td><td align="left">22.45</td><td char="." align="char">7.99</td><td char="." align="char">2.76</td><td char="." align="char">5.29</td><td char="." align="char">2.65</td><td align="left">498</td></tr><tr><td align="left">R SSC2</td><td char="." align="char">8.40</td><td align="left">− 54.54</td><td char="." align="char">57.95</td><td char="." align="char">4.44</td><td char="." align="char">5.31</td><td char="." align="char">3.06</td><td align="left">944</td></tr><tr><td align="left">R THLMS</td><td char="." align="char">5.10</td><td align="left">− 13.99</td><td char="." align="char">3.07</td><td char="." align="char">7.84</td><td char="." align="char">6.60</td><td char="." align="char">5.61</td><td align="left">3462</td></tr><tr><td align="left">R ACC</td><td char="." align="char">− 4.08</td><td align="left">− 5.08</td><td char="." align="char">39.15</td><td char="." align="char">6.13</td><td char="." align="char">15.07</td><td char="." align="char">3.86</td><td align="left">4797</td></tr><tr><td align="left">R PONS</td><td char="." align="char">0.76</td><td align="left">− 25.31</td><td char="." align="char">− 20.39</td><td char="." align="char">2.75</td><td char="." align="char">5.32</td><td char="." align="char">4.23</td><td align="left">1076</td></tr><tr><td align="left">L BA11</td><td char="." align="char">− 30.80</td><td align="left">8.05</td><td char="." align="char">− 0.19</td><td char="." align="char">11.25</td><td char="." align="char">7.89</td><td char="." align="char">10.25</td><td align="left">11,841</td></tr><tr><td align="left">L THLMS</td><td char="." align="char">− 23.76</td><td align="left">− 21.65</td><td char="." align="char">− 3.58</td><td char="." align="char">7.94</td><td char="." align="char">2.66</td><td char="." align="char">3.84</td><td align="left">1366</td></tr><tr><td align="left">L PFC</td><td char="." align="char">− 32.95</td><td align="left">31.70</td><td char="." align="char">30.25</td><td char="." align="char">3.55</td><td char="." align="char">5.31</td><td char="." align="char">3.87</td><td align="left">871</td></tr></tbody></table></div>Several regions that were seen in a previous study linked with pain modulation with specific Talairach coordinates. Indication of left or right given as L or R respectively.INS insula, DLPFC dorsal lateral prefrontal cortex, SSC somatosensory cortex, THLMS thalamus, ACC anterior cingulate cortex, PFC prefrontal cortex, BA Brodmann Area.</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Demographic information.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2"><label>Table 2</label><caption><p>Demographic information.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Real (N = 14)</th><th align="left">Sham (N = 12)</th><th align="left">Real vs Sham<break/><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="4"><bold>Gender</bold></td></tr><tr><td align="left">Males</td><td align="left">12</td><td align="left">8</td><td align="left">–</td></tr><tr><td align="left">Females</td><td align="left">2</td><td align="left">4</td><td align="left">–</td></tr><tr><td align="left"><bold>Cause of TBI</bold></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Blast</td><td align="left">5</td><td align="left">5</td><td align="left">–</td></tr><tr><td align="left">Non-blast</td><td align="left">7</td><td align="left">5</td><td align="left">–</td></tr><tr><td align="left">Both</td><td align="left">2</td><td align="left">2</td><td align="left">–</td></tr><tr><td align="left"><bold>Duration in months of MTBI-HA ± SD</bold></td><td align="left">95 ± 83</td><td align="left">105 ± 61</td><td align="left">–</td></tr><tr><td align="left" colspan="4"><bold>Number of subjects using medications</bold></td></tr><tr><td align="left">Triptans</td><td align="left">5</td><td align="left">7</td><td align="left">–</td></tr><tr><td align="left">TCA</td><td align="left">8</td><td align="left">6</td><td align="left">–</td></tr><tr><td align="left">NSAID</td><td align="left">3</td><td align="left">5</td><td align="left">–</td></tr><tr><td align="left">Gabapentanoid</td><td align="left">4</td><td align="left">1</td><td align="left">–</td></tr><tr><td align="left">Acetaminophen</td><td align="left">1</td><td align="left">1</td><td align="left">–</td></tr><tr><td align="left">SSRI</td><td align="left">0</td><td align="left">2</td><td align="left">–</td></tr><tr><td align="left">AED</td><td align="left">0</td><td align="left">3</td><td align="left">–</td></tr><tr><td align="left">Opioid</td><td align="left">0</td><td align="left">1</td><td align="left">–</td></tr><tr><td align="left"><bold>Average age ± SD</bold></td><td align="left">33.0 ± 8</td><td align="left">35.6 ± 8</td><td align="left">–</td></tr><tr><td align="left"><bold>Average RMT ± SD</bold></td><td align="left">55.5 ± 13.7</td><td align="left">52.6 ± 8.7</td><td align="left">–</td></tr></tbody></table><table-wrap-foot><p><italic>RMT</italic> Resting Motor Threshold;—no significant difference between groups.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic information.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Real (N = 14)</th><th align="left">Sham (N = 12)</th><th align="left">Real vs ShamP-value</th></tr></thead><tbody><tr><td align="left" colspan="4">Gender</td></tr><tr><td align="left">Males</td><td align="left">12</td><td align="left">8</td><td align="left">–</td></tr><tr><td align="left">Females</td><td align="left">2</td><td align="left">4</td><td align="left">–</td></tr><tr><td align="left">Cause of TBI</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Blast</td><td align="left">5</td><td align="left">5</td><td align="left">–</td></tr><tr><td align="left">Non-blast</td><td align="left">7</td><td align="left">5</td><td align="left">–</td></tr><tr><td align="left">Both</td><td align="left">2</td><td align="left">2</td><td align="left">–</td></tr><tr><td align="left">Duration in months of MTBI-HA ± SD</td><td align="left">95 ± 83</td><td align="left">105 ± 61</td><td align="left">–</td></tr><tr><td align="left" colspan="4">Number of subjects using medications</td></tr><tr><td align="left">Triptans</td><td align="left">5</td><td align="left">7</td><td align="left">–</td></tr><tr><td align="left">TCA</td><td align="left">8</td><td align="left">6</td><td align="left">–</td></tr><tr><td align="left">NSAID</td><td align="left">3</td><td align="left">5</td><td align="left">–</td></tr><tr><td align="left">Gabapentanoid</td><td align="left">4</td><td align="left">1</td><td align="left">–</td></tr><tr><td align="left">Acetaminophen</td><td align="left">1</td><td align="left">1</td><td align="left">–</td></tr><tr><td align="left">SSRI</td><td align="left">0</td><td align="left">2</td><td align="left">–</td></tr><tr><td align="left">AED</td><td align="left">0</td><td align="left">3</td><td align="left">–</td></tr><tr><td align="left">Opioid</td><td align="left">0</td><td align="left">1</td><td align="left">–</td></tr><tr><td align="left">Average age ± SD</td><td align="left">33.0 ± 8</td><td align="left">35.6 ± 8</td><td align="left">–</td></tr><tr><td align="left">Average RMT ± SD</td><td align="left">55.5 ± 13.7</td><td align="left">52.6 ± 8.7</td><td align="left">–</td></tr></tbody></table></div>RMT Resting Motor Threshold;—no significant difference between groups.</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Left prefrontal cortex evoked HP fMRI comparisons.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab3"><label>Table 3</label><caption><p>Left prefrontal cortex evoked HP fMRI comparisons.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">F value</th><th align="left"><italic>P</italic> value</th><th align="left">T value</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td char="–" align="char">Pre-REAL – Pre-SHAM</td><td char="." align="char">0.03</td><td char="." align="char">0.872</td><td align="left">− 0.25</td><td char="." align="char">0.800</td></tr><tr><td char="–" align="char">Post-REAL – Pre-REAL</td><td char="." align="char">5.66</td><td char="." align="char">0.025</td><td align="left">3.19</td><td char="." align="char"><bold>&lt; 0.002</bold></td></tr><tr><td char="–" align="char">Post-SHAM –Pre-SHAM</td><td char="." align="char">0.43</td><td char="." align="char">0.520</td><td align="left">− 1.08</td><td char="." align="char">0.281</td></tr><tr><td char="–" align="char">Post-REAL – Post-SHAM</td><td char="." align="char">2.92</td><td char="." align="char">0.102</td><td align="left">1.66</td><td char="." align="char">0.100</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Left prefrontal cortex evoked HP fMRI comparisons.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">F value</th><th align="left">P value</th><th align="left">T value</th><th align="left">P value</th></tr></thead><tbody><tr><td char="–" align="char">Pre-REAL – Pre-SHAM</td><td char="." align="char">0.03</td><td char="." align="char">0.872</td><td align="left">− 0.25</td><td char="." align="char">0.800</td></tr><tr><td char="–" align="char">Post-REAL – Pre-REAL</td><td char="." align="char">5.66</td><td char="." align="char">0.025</td><td align="left">3.19</td><td char="." align="char">&lt; 0.002</td></tr><tr><td char="–" align="char">Post-SHAM –Pre-SHAM</td><td char="." align="char">0.43</td><td char="." align="char">0.520</td><td align="left">− 1.08</td><td char="." align="char">0.281</td></tr><tr><td char="–" align="char">Post-REAL – Post-SHAM</td><td char="." align="char">2.92</td><td char="." align="char">0.102</td><td align="left">1.66</td><td char="." align="char">0.100</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>Tab4</table-id><table-label>Table 4</table-label><table-caption>Table of means (± SD) of headache assessments and significant findings.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab4"><label>Table 4</label><caption><p>Table of means (± SD) of headache assessments and significant findings.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Real ± SD</th><th align="left">Sham ± SD</th><th align="left"/><th align="left">df</th><th align="left">F</th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="7"><bold>Debilitating headache frequency</bold></td></tr><tr><td align="left">Baseline</td><td char="." align="char">2.44 ± 1.56</td><td char="." align="char">3.95 ± 1.83</td><td align="left">Overall Treatment versus Visit</td><td char="," align="char">2,48</td><td char="." align="char">3.18</td><td char="." align="char"><bold>0.050</bold></td></tr><tr><td align="left">1-Week Post-TX</td><td char="." align="char">1.52 ± 1.45</td><td char="." align="char">3.92 ± 1.80</td><td align="left">Baseline versus 1-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">7.11</td><td char="." align="char"><bold>0.014</bold></td></tr><tr><td align="left">4-Week Post-TX</td><td char="." align="char">1.38 ± 1.37</td><td char="." align="char">4.01 ± 1.92</td><td align="left">Baseline versus 4-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">3.99</td><td char="." align="char">0.057</td></tr><tr><td align="left" colspan="7"><bold>Daily headache intensity</bold></td></tr><tr><td align="left">Baseline</td><td char="." align="char">4.9 ± 1.7</td><td char="." align="char">4.9 ± 1.4</td><td align="left">Overall Treatment versus Visit</td><td char="," align="char">2,48</td><td char="." align="char">9.24</td><td char="." align="char"><bold> &lt; 0.001</bold></td></tr><tr><td align="left">1-Week Post-TX</td><td char="." align="char">3.5 ± 2.0</td><td char="." align="char">4.8 ± 1.4</td><td align="left">Baseline versus 1-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">17.29</td><td char="." align="char"><bold> &lt; 0.001</bold></td></tr><tr><td align="left">4-Week Post-TX</td><td char="." align="char">3.6 ± 2.0</td><td char="." align="char">4.8 ± 1.6</td><td align="left">Baseline versus 4-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">9.91</td><td char="." align="char"><bold>0.004</bold></td></tr><tr><td align="left" colspan="7"><bold>Prevalence of persistent headaches</bold></td></tr><tr><td align="left">Baseline</td><td char="." align="char">1.00 ± 0.00</td><td char="." align="char">1.00 ± 0.00</td><td align="left">Overall Treatment versus Visit</td><td char="," align="char">2,48</td><td char="." align="char">3.50</td><td char="." align="char"><bold>0.038</bold></td></tr><tr><td align="left">1-Week Post-TX</td><td char="." align="char">0.50 ± 0.52</td><td char="." align="char">0.92 ± 0.29</td><td align="left">Baseline versus 1-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">6.10</td><td char="." align="char"><bold>0.021</bold></td></tr><tr><td align="left">4-Week Post-TX</td><td char="." align="char">0.43 ± 0.51</td><td char="." align="char">0.75 ± 0.45</td><td align="left">Baseline versus 4-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">2.82</td><td char="." align="char">0.106</td></tr></tbody></table><table-wrap-foot><p>Post-TX: post-treatment.</p><p>The bold values represent significance of <italic>p</italic> &lt; 0.05</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 4<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Table of means (± SD) of headache assessments and significant findings.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Real ± SD</th><th align="left">Sham ± SD</th><th align="left"/><th align="left">df</th><th align="left">F</th><th align="left">p-value</th></tr></thead><tbody><tr><td align="left" colspan="7">Debilitating headache frequency</td></tr><tr><td align="left">Baseline</td><td char="." align="char">2.44 ± 1.56</td><td char="." align="char">3.95 ± 1.83</td><td align="left">Overall Treatment versus Visit</td><td char="," align="char">2,48</td><td char="." align="char">3.18</td><td char="." align="char">0.050</td></tr><tr><td align="left">1-Week Post-TX</td><td char="." align="char">1.52 ± 1.45</td><td char="." align="char">3.92 ± 1.80</td><td align="left">Baseline versus 1-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">7.11</td><td char="." align="char">0.014</td></tr><tr><td align="left">4-Week Post-TX</td><td char="." align="char">1.38 ± 1.37</td><td char="." align="char">4.01 ± 1.92</td><td align="left">Baseline versus 4-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">3.99</td><td char="." align="char">0.057</td></tr><tr><td align="left" colspan="7">Daily headache intensity</td></tr><tr><td align="left">Baseline</td><td char="." align="char">4.9 ± 1.7</td><td char="." align="char">4.9 ± 1.4</td><td align="left">Overall Treatment versus Visit</td><td char="," align="char">2,48</td><td char="." align="char">9.24</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left">1-Week Post-TX</td><td char="." align="char">3.5 ± 2.0</td><td char="." align="char">4.8 ± 1.4</td><td align="left">Baseline versus 1-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">17.29</td><td char="." align="char"> &lt; 0.001</td></tr><tr><td align="left">4-Week Post-TX</td><td char="." align="char">3.6 ± 2.0</td><td char="." align="char">4.8 ± 1.6</td><td align="left">Baseline versus 4-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">9.91</td><td char="." align="char">0.004</td></tr><tr><td align="left" colspan="7">Prevalence of persistent headaches</td></tr><tr><td align="left">Baseline</td><td char="." align="char">1.00 ± 0.00</td><td char="." align="char">1.00 ± 0.00</td><td align="left">Overall Treatment versus Visit</td><td char="," align="char">2,48</td><td char="." align="char">3.50</td><td char="." align="char">0.038</td></tr><tr><td align="left">1-Week Post-TX</td><td char="." align="char">0.50 ± 0.52</td><td char="." align="char">0.92 ± 0.29</td><td align="left">Baseline versus 1-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">6.10</td><td char="." align="char">0.021</td></tr><tr><td align="left">4-Week Post-TX</td><td char="." align="char">0.43 ± 0.51</td><td char="." align="char">0.75 ± 0.45</td><td align="left">Baseline versus 4-Week Post-TX</td><td char="," align="char">1,24</td><td char="." align="char">2.82</td><td char="." align="char">0.106</td></tr></tbody></table></div>Post-TX: post-treatment.The bold values represent significance of p &lt; 0.05</transformed-table></extracted-table></extracted-tables-set>